Loading patent…
AssigneeSociete des Produits Nestle S.A.
InventorsTimothy James Wooster, Ebenezer Satyaraj, Eddy Gombas, Beat Gerber
Estimating the term…
Compositions and methods reduce symptoms of human allergy to cats. The effectiveness of a molecule which specifically binds to Feline domesticus allergen number 1 (Fel D1) is enhanced by prolonging the time the immunoglobulin stays within the mouth of a cat to whom the anti-Fel D1 molecule is administered in a pet food. The compositions and methods use a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule, and the hydrogel is based on gelatin, collagen peptides, or gelatin and collagen peptides; and carrageenan. The methods of making the powder provide a high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the anti-Fel D1 molecule in the cat's mouth.
A food grade powder providing sustained release of an anti-Fel D1 molecule, the food grade powder comprising a dried hydrogel and the anti-Fel D1 molecule;
A method of making a food grade powder providing sustained release of an anti-Fel D1 molecule, the method comprising:
A method of making a food grade powder providing sustained release of an anti-Fel D1 molecule, the method comprising:
A method of making a food grade powder providing sustained release of an anti-Fel D1 molecule, the method comprises spray drying a solution comprising the anti-Fel D1 molecule and 5.0 to 20.0 wt. % of gelatin and collagen peptides having a molecular weight between 2,000 and 1 million Daltons and or a bloom value of 40 to 300 to form a dried hydrogel in which the anti-Fel D1 molecule is encapsulated.
Dependencies are inferred from the claim text.